Skip to content

The effects of I stage cardiac rehabilitation on cardiopulmonary function in patients undergoing open heart surgery: a randomized controlled study.

The effects of I stage cardiac rehabilitation on cardiopulmonary function in patients undergoing open heart surgery: a randomized controlled study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011445
Enrollment
Unknown
Registered
2017-05-20
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After open heart surgery

Interventions

General exercise rehabilitation group:General exercise rehabilitation
Intensive exercise rehabilitation group: Intensive exercise rehabilitation

Sponsors

Fuwai Hospital; Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-70 years who are eligible for coronary artery bypass grafting (CABG) and / or cardiac valve replacement surgery and who have planned thoracotomy

Exclusion criteria

Exclusion criteria: 1) pregnant women; 2) participated in other clinical or clinical rehabilitation trials a month ago; 3) there are other causes of serious physical activity other than coronary heart disease; 4) with uncontrolled tachycardia (quiet heart rate was 120 beats per minute); 5) with uncontrolled shortness of breath (quiet breathing rate > 30 beats per minute); 6) have not control respiratory failure [oxygen saturation (SPO2) = 90%]; 7) Uncontrolled hypertension [pre exercise systolic blood pressure (SBP) > 180mmHg or diastolic blood pressure (DBP) > 110mmHg; 8) there is uncontrolled malignant arrhythmia which leads to hemodynamic instability; 9) confirmed or suspected pseudoaneurysm, arterial dissection; 10) uncontrolled septic shock and sepsis; 11) severe valvular disease before operation or acute heart failure in patients with heart failure; 12) combined with clinicians who believe that exercise can lead to deterioration of the nervous system, motor system disease or rheumatic disease; 13) the installation of artificial pacemaker; 14) patients unwilling to cooperate.

Design outcomes

Primary

MeasureTime frame
PVO2;

Secondary

MeasureTime frame
Peak cardiac output;Resting cardiac output;Cardiac NYHA grading;Echocardiography;

Countries

China

Contacts

Public ContactXue Feng

Fuwai Hospital; Chinese Academy of Medical Sciences

29611290@qq.com+86 15601378512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026